The Plant-Based Biologics Market is driven by growing demand for sustainable alternatives
The Plant-Based Biologics Market involves the production of biologics or biopharmaceuticals using plant systems and plant cell culture techniques as an alternative to bacterial and mammalian cell-based productions. Plant-based biologics production platforms can manufacture complex therapeutic proteins including monoclonal antibodies, peptides, and vaccines at commercial scale with human-compatible post-translational modifications similar to mammalian cell systems…
Plant-Based Biologics: Emerging Alternative Platform for Biologics Production
Plants have emerged as a viable alternative platform for the production of biologics. Many biopharmaceutical drugs today including monoclonal antibodies, vaccines and clotting factors have traditionally been produced in mammalian cell culture systems or recombinant microorganisms like E.coli. However, plant-based expression systems offer several advantages over these traditional platforms for production of certain biologics. Advantages…